AU766057B2 - Screening test for early detection of colorectal cancer - Google Patents

Screening test for early detection of colorectal cancer Download PDF

Info

Publication number
AU766057B2
AU766057B2 AU10227/00A AU1022700A AU766057B2 AU 766057 B2 AU766057 B2 AU 766057B2 AU 10227/00 A AU10227/00 A AU 10227/00A AU 1022700 A AU1022700 A AU 1022700A AU 766057 B2 AU766057 B2 AU 766057B2
Authority
AU
Australia
Prior art keywords
mucus
cancer
sample
reagent
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU10227/00A
Other languages
English (en)
Other versions
AU1022700A (en
Inventor
Jacek Chociej
Jiri J. Krepinsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procyon Biopharma Inc
Original Assignee
Procyon Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002253093A external-priority patent/CA2253093A1/en
Application filed by Procyon Biopharma Inc filed Critical Procyon Biopharma Inc
Publication of AU1022700A publication Critical patent/AU1022700A/en
Assigned to PROCYON BIOPHARMA INC. reassignment PROCYON BIOPHARMA INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: KREPINSKY, JIRI J.
Application granted granted Critical
Publication of AU766057B2 publication Critical patent/AU766057B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AU10227/00A 1998-11-06 1999-11-03 Screening test for early detection of colorectal cancer Ceased AU766057B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA2253093 1998-11-06
CA002253093A CA2253093A1 (en) 1998-11-06 1998-11-06 Screening test for early detection of colorectal cancer
US09/270,103 US6187591B1 (en) 1998-11-06 1999-03-16 Screening test for early detection of colorectal cancer
US09/270103 1999-03-16
PCT/CA1999/001034 WO2000028329A1 (en) 1998-11-06 1999-11-03 Screening test for early detection of colorectal cancer

Publications (2)

Publication Number Publication Date
AU1022700A AU1022700A (en) 2000-05-29
AU766057B2 true AU766057B2 (en) 2003-10-09

Family

ID=25680625

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10227/00A Ceased AU766057B2 (en) 1998-11-06 1999-11-03 Screening test for early detection of colorectal cancer

Country Status (6)

Country Link
EP (1) EP1125131A1 (ja)
JP (1) JP2002529739A (ja)
AU (1) AU766057B2 (ja)
BR (1) BR9915005A (ja)
IL (1) IL139545A0 (ja)
WO (1) WO2000028329A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2299210A1 (en) * 2000-02-17 2001-08-17 Gregory R. Wade A method of assessing the biological status of cancer development

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416025A (en) * 1993-11-29 1995-05-16 Krepinsky; Jiri J. Screening test for early detection of colorectal cancer

Also Published As

Publication number Publication date
WO2000028329A1 (en) 2000-05-18
BR9915005A (pt) 2001-11-20
JP2002529739A (ja) 2002-09-10
IL139545A0 (en) 2002-02-10
AU1022700A (en) 2000-05-29
EP1125131A1 (en) 2001-08-22

Similar Documents

Publication Publication Date Title
EP0731914B1 (en) Screening test for early detection of colorectal neoplasia
Decenzo et al. Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma
US6187591B1 (en) Screening test for early detection of colorectal cancer
CA2429526A1 (en) Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
US20070292900A1 (en) Zinc-based screening test and kit for early diagnosis of prostate cancer
HU207584B (en) Method and set for diagnosing appendicitis by detection of delta-hydroxy-hippuric acid
Sánchez-Carbayo et al. Initial evaluation of the new urinary bladder cancer rapid test in the detection of transitional cell carcinoma of the bladder
US20020022240A1 (en) Method of assessing the biological status of cancer development
WO2004094652A2 (en) Zinc-based screening test and kit for early diagnosis of prostate cancer
JP5350570B2 (ja) 蛍光性コバラミンおよびその使用
WO1997045727A1 (en) Method of detecting gynecological carcinomas
AU766057B2 (en) Screening test for early detection of colorectal cancer
CA2352184C (en) Screening test for early detection of colorectal cancer
CA2176508C (en) Screening test for early detection of colorectal neoplasia
Gunduz et al. Fluoresceinated estrone binding by cells from human breast cancers obtained by needle aspiration
US20070207509A1 (en) Zinc-based screening test and kit for early diagnosis of prostate cancer
MXPA00012243A (en) Screening test for early detection of colorectal cancer
JP2001289861A (ja) 腫瘍マーカーによる癌の評価方法
CN113267626B (zh) 一种用于高危人群贲门腺癌早期筛查的试纸条
RU2530557C1 (ru) Способ дифференциальной диагностики злокачественной и доброкачественной патологии молочной железы
Bir et al. Apoptotic cell death and its relationship to gastric carcinogenesis
Romas et al. A new method for determination of urinary tryptophan metabolites in bladder carcinoma
CN113721021A (zh) Prkcz自身抗体在食管鳞癌辅助诊断中的应用
SCHEINER et al. Fluorescence Cytologic Screening: An Aid in the Diagnosis of Gastric Cancer
CA2335773A1 (en) A method of assessing the biological status of pathology in epithelial tissue

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: PROCYON BIOPHARMA INC.

Free format text: THE FORMER OWNER WAS: JIRI J. KREPINSKY

FGA Letters patent sealed or granted (standard patent)